Skip to content
Screener

Quince Therapeutics, Inc. QNCX Q3 2025 earnings

Reported November 12, 2025 · Before market open

EPS-$0.25Miss by $0.05
EPS estimate-$0.20

Next report

Nov 11, 2026 (in 2 months)
EPS estimate-$4.03

FAQ

When did Quince Therapeutics, Inc. report Q3 2025 earnings?
Quince Therapeutics, Inc. (QNCX) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Quince Therapeutics, Inc.'s Q3 2025 revenue and EPS?
Quince Therapeutics, Inc. reported eps of $-0.25 for Q3 2025.
Did Quince Therapeutics, Inc. beat estimates in Q3 2025?
EPS missed the consensus estimate of $-0.20 by $0.05.
How did Quince Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 92.3% from $-0.13.
Where can I find Quince Therapeutics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-277523) and the 10-Q periodic report (0001193125-25-277529) directly on SEC EDGAR. The filing index links above go to sec.gov.